| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,971 |
8,111 |
$1.84M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,951 |
2,613 |
$1.04M |
| 80053 |
Comprehensive metabolic panel |
18,202 |
15,363 |
$174K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
156 |
106 |
$77K |
| 71046 |
Radiologic examination, chest; 2 views |
560 |
497 |
$50K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
242 |
227 |
$29K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,140 |
250 |
$29K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,155 |
3,437 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
575 |
533 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,226 |
1,099 |
$17K |
| 81025 |
|
1,907 |
1,680 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
5,222 |
3,973 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
892 |
771 |
$12K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
616 |
159 |
$9K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
36 |
36 |
$8K |
| 97032 |
|
782 |
177 |
$7K |
| 83735 |
|
999 |
856 |
$6K |
| 81001 |
|
2,393 |
2,053 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
76 |
67 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
27 |
26 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
257 |
224 |
$3K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
48 |
47 |
$3K |
| 0012A |
|
142 |
99 |
$3K |
| 86328 |
|
91 |
64 |
$3K |
| 0011A |
|
157 |
115 |
$2K |
| 76801 |
|
14 |
13 |
$2K |
| 86318 |
|
169 |
158 |
$2K |
| 80305 |
|
150 |
133 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
216 |
189 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
153 |
125 |
$1K |
| 97162 |
|
30 |
24 |
$1K |
| 86769 |
|
27 |
27 |
$1K |
| 0013A |
|
35 |
26 |
$1K |
| 81015 |
|
1,121 |
896 |
$559.56 |
| 0002A |
|
77 |
18 |
$452.12 |
| 91301 |
|
315 |
242 |
$222.48 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13 |
12 |
$82.33 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
13 |
12 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
131 |
106 |
$0.00 |
| J7799 |
Noc drugs, other than inhalation drugs, administered through dme |
52 |
43 |
$0.00 |
| 00000 |
|
76 |
52 |
$0.00 |
| 91300 |
|
143 |
60 |
$0.00 |
| J7642 |
Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
135 |
105 |
$0.00 |